Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The PIM family kinases are a group of serine/threonine kinases consisting of PIM1, PIM2, and PIM3. They play significant roles in cell survival, proliferation, apoptosis, and oncogenesis. These constitutively active enzymes are involved in cell cycle progression, metabolism, and migration. They are overexpressed in many cancers, especially hematologic malignancies and solid tumors. Due to their role in cancer cell survival/proliferation, PIM kinases are considered promising targets for anticancer drug development.
Inhibition of PIM kinase activity, blocking pro-survival pathways and reversing drug resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PIM Family Kinases (PIM Kinases).